1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Humira 1.2.3 Enbrel 1.2.4 Remicade 1.2.5 Simponi/Simponi Aria 1.2.6 Cimzia 1.2.7 Biosimilars 1.3 Market by Application 1.3.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Rheumatoid Arthritis 1.3.3 Psoriasis 1.3.4 Psoriatic Arthritis 1.3.5 Crohn’s Disease 1.3.6 Ulcerative Colitis 1.3.7 Ankylosing Spondylitis 1.3.8 Juvenile Idiopathic Arthritis 1.3.9 Hidradenitis Suppurativa 1.3.10 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Perspective (2016-2027) 2.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Growth Trends by Regions 2.2.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Industry Dynamic 2.3.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Trends 2.3.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Drivers 2.3.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Challenges 2.3.4 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Tumor Necrosis Factor (TNF) Inhibitor Drugs Players by Revenue 3.1.1 Global Top Tumor Necrosis Factor (TNF) Inhibitor Drugs Players by Revenue (2016-2021) 3.1.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue 3.4 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Concentration Ratio 3.4.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in 2020 3.5 Tumor Necrosis Factor (TNF) Inhibitor Drugs Key Players Head office and Area Served 3.6 Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Solution and Service 3.7 Date of Enter into Tumor Necrosis Factor (TNF) Inhibitor Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Tumor Necrosis Factor (TNF) Inhibitor Drugs Breakdown Data by Type 4.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Historic Market Size by Type (2016-2021) 4.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Forecasted Market Size by Type (2022-2027) 5 Tumor Necrosis Factor (TNF) Inhibitor Drugs Breakdown Data by Application 5.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Historic Market Size by Application (2016-2021) 5.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size (2016-2027) 6.2 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type 6.2.1 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2021) 6.2.2 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2022-2027) 6.2.3 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2027) 6.3 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application 6.3.1 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2021) 6.3.2 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2022-2027) 6.3.3 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2027) 6.4 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country 6.4.1 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2016-2021) 6.4.2 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size (2016-2027) 7.2 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type 7.2.1 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2021) 7.2.2 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2022-2027) 7.2.3 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2027) 7.3 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application 7.3.1 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2021) 7.3.2 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2022-2027) 7.3.3 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2027) 7.4 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country 7.4.1 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2016-2021) 7.4.2 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size (2016-2027) 8.2 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type 8.2.1 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application 8.3.1 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Region 8.4.1 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size (2016-2027) 9.2 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type 9.2.1 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2027) 9.3 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application 9.3.1 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2027) 9.4 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country 9.4.1 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size (2016-2027) 10.2 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type 10.2.1 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application 10.3.1 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country 10.4.1 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AbbVie Inc. 11.1.1 AbbVie Inc. Company Details 11.1.2 AbbVie Inc. Business Overview 11.1.3 AbbVie Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction 11.1.4 AbbVie Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) 11.1.5 AbbVie Inc. Recent Development 11.2 Amgen Inc. 11.2.1 Amgen Inc. Company Details 11.2.2 Amgen Inc. Business Overview 11.2.3 Amgen Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction 11.2.4 Amgen Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) 11.2.5 Amgen Inc. Recent Development 11.3 Johnson & Johnson Services, Inc. 11.3.1 Johnson & Johnson Services, Inc. Company Details 11.3.2 Johnson & Johnson Services, Inc. Business Overview 11.3.3 Johnson & Johnson Services, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction 11.3.4 Johnson & Johnson Services, Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) 11.3.5 Johnson & Johnson Services, Inc. Recent Development 11.4 UCB S.A. 11.4.1 UCB S.A. Company Details 11.4.2 UCB S.A. Business Overview 11.4.3 UCB S.A. Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction 11.4.4 UCB S.A. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) 11.4.5 UCB S.A. Recent Development 11.5 Novartis International AG 11.5.1 Novartis International AG Company Details 11.5.2 Novartis International AG Business Overview 11.5.3 Novartis International AG Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction 11.5.4 Novartis International AG Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) 11.5.5 Novartis International AG Recent Development 11.6 Pfizer, Inc. 11.6.1 Pfizer, Inc. Company Details 11.6.2 Pfizer, Inc. Business Overview 11.6.3 Pfizer, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction 11.6.4 Pfizer, Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) 11.6.5 Pfizer, Inc. Recent Development 11.7 Merck & co., Inc. 11.7.1 Merck & co., Inc. Company Details 11.7.2 Merck & co., Inc. Business Overview 11.7.3 Merck & co., Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction 11.7.4 Merck & co., Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) 11.7.5 Merck & co., Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Humira Table 3. Key Players of Enbrel Table 4. Key Players of Remicade Table 5. Key Players of Simponi/Simponi Aria Table 6. Key Players of Cimzia Table 7. Key Players of Biosimilars Table 8. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 11. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Regions (2016-2021) Table 12. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 13. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Regions (2022-2027) Table 14. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Trends Table 15. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Drivers Table 16. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Challenges Table 17. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Restraints Table 18. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Players (2016-2021) & (US$ Million) Table 19. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Players (2016-2021) Table 20. Global Top Tumor Necrosis Factor (TNF) Inhibitor Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs as of 2020) Table 21. Ranking of Global Top Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies by Revenue (US$ Million) in 2020 Table 22. Global 5 Largest Players Market Share by Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (CR5 and HHI) & (2016-2021) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Solution and Service Table 25. Date of Enter into Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2021) (US$ Million) Table 28. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Type (2016-2021) Table 29. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 30. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 31. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 32. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Application (2016-2021) Table 33. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 34. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 35. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2021) (US$ Million) Table 36. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2022-2027) & (US$ Million) Table 37. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2021) (US$ Million) Table 38. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2022-2027) & (US$ Million) Table 39. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2016-2021) & (US$ Million) Table 40. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2022-2027) & (US$ Million) Table 41. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2021) (US$ Million) Table 42. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2022-2027) & (US$ Million) Table 43. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2021) (US$ Million) Table 44. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2022-2027) & (US$ Million) Table 45. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2016-2021) & (US$ Million) Table 46. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2022-2027) & (US$ Million) Table 47. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2021) (US$ Million) Table 48. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2022-2027) & (US$ Million) Table 49. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2021) (US$ Million) Table 50. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2022-2027) & (US$ Million) Table 51. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Region (2016-2021) & (US$ Million) Table 52. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Region (2022-2027) & (US$ Million) Table 53. Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2021) (US$ Million) Table 54. Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2022-2027) & (US$ Million) Table 55. Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2021) (US$ Million) Table 56. Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2022-2027) & (US$ Million) Table 57. Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2016-2021) & (US$ Million) Table 58. Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2022-2027) & (US$ Million) Table 59. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2016-2021) (US$ Million) Table 60. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2022-2027) & (US$ Million) Table 61. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2016-2021) (US$ Million) Table 62. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2022-2027) & (US$ Million) Table 63. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2016-2021) & (US$ Million) Table 64. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Country (2022-2027) & (US$ Million) Table 65. AbbVie Inc. Company Details Table 66. AbbVie Inc. Business Overview Table 67. AbbVie Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Table 68. AbbVie Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) & (US$ Million) Table 69. AbbVie Inc. Recent Development Table 70. Amgen Inc. Company Details Table 71. Amgen Inc. Business Overview Table 72. Amgen Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Table 73. Amgen Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) & (US$ Million) Table 74. Amgen Inc. Recent Development Table 75. Johnson & Johnson Services, Inc. Company Details Table 76. Johnson & Johnson Services, Inc. Business Overview Table 77. Johnson & Johnson Services, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Table 78. Johnson & Johnson Services, Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) & (US$ Million) Table 79. Johnson & Johnson Services, Inc. Recent Development Table 80. UCB S.A. Company Details Table 81. UCB S.A. Business Overview Table 82. UCB S.A. Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Table 83. UCB S.A. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) & (US$ Million) Table 84. UCB S.A. Recent Development Table 85. Novartis International AG Company Details Table 86. Novartis International AG Business Overview Table 87. Novartis International AG Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Table 88. Novartis International AG Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) & (US$ Million) Table 89. Novartis International AG Recent Development Table 90. Pfizer, Inc. Company Details Table 91. Pfizer, Inc. Business Overview Table 92. Pfizer, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Table 93. Pfizer, Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) & (US$ Million) Table 94. Pfizer, Inc. Recent Development Table 95. Merck & co., Inc. Company Details Table 96. Merck & co., Inc. Business Overview Table 97. Merck & co., Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Table 98. Merck & co., Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) & (US$ Million) Table 99. Merck & co., Inc. Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Type: 2020 VS 2027 Figure 2. Humira Features Figure 3. Enbrel Features Figure 4. Remicade Features Figure 5. Simponi/Simponi Aria Features Figure 6. Cimzia Features Figure 7. Biosimilars Features Figure 8. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application: 2020 VS 2027 Figure 9. Rheumatoid Arthritis Case Studies Figure 10. Psoriasis Case Studies Figure 11. Psoriatic Arthritis Case Studies Figure 12. Crohn’s Disease Case Studies Figure 13. Ulcerative Colitis Case Studies Figure 14. Ankylosing Spondylitis Case Studies Figure 15. Juvenile Idiopathic Arthritis Case Studies Figure 16. Hidradenitis Suppurativa Case Studies Figure 17. Others Case Studies Figure 18. Tumor Necrosis Factor (TNF) Inhibitor Drugs Report Years Considered Figure 19. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 20. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 21. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Regions: 2020 VS 2027 Figure 22. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Regions (2022-2027) Figure 23. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Players in 2020 Figure 24. Global Top Tumor Necrosis Factor (TNF) Inhibitor Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs as of 2020 Figure 25. The Top 10 and 5 Players Market Share by Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in 2020 Figure 26. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Type (2016-2021) Figure 27. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Type (2022-2027) Figure 28. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Type (2016-2027) Figure 30. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application (2016-2027) Figure 31. North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Country (2016-2027) Figure 32. United States Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Canada Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Type (2016-2027) Figure 36. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application (2016-2027) Figure 37. Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Country (2016-2027) Figure 38. Germany Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. France Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. U.K. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Italy Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Russia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Nordic Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Type (2016-2027) Figure 46. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application (2016-2027) Figure 47. Asia-Pacific Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Region (2016-2027) Figure 48. China Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. South Korea Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. India Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Australia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Type (2016-2027) Figure 56. Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application (2016-2027) Figure 57. Latin America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Country (2016-2027) Figure 58. Mexico Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Brazil Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Type (2016-2027) Figure 62. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application (2016-2027) Figure 63. Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Country (2016-2027) Figure 64. Turkey Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 65. Saudi Arabia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 66. UAE Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 67. AbbVie Inc. Revenue Growth Rate in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) Figure 68. Amgen Inc. Revenue Growth Rate in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) Figure 69. Johnson & Johnson Services, Inc. Revenue Growth Rate in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) Figure 70. UCB S.A. Revenue Growth Rate in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) Figure 71. Novartis International AG Revenue Growth Rate in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) Figure 72. Pfizer, Inc. Revenue Growth Rate in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) Figure 73. Merck & co., Inc. Revenue Growth Rate in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2016-2021) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed